A trial testing seralutinib for pulmonary arterial hypertension narrowly missed its main goal, but benefits were seen among ...

A community-based multilevel intervention (STRIVE) showed no overall significant effect on BMI z-scores among rural Hispanic children.

Dermata Therapeutics (DRMA) announced that additional analysis of topline data from its Phase 3 STAR-1 trial showed that XYNGARI had a statistically significant difference from placebo on three ...

ICIs have transformed NSCLC treatment, but disparities in trial enrollment and efficacy reporting persist, limiting insights into treatment benefits across demographics. A meta-analysis of 21 trials ...